Lombard Medical Limited
Daniel Wood is an experienced quality and compliance professional with a background in medical engineering. Currently serving as the Quality Project & Compliance Lead at Lombard Endovastec since May 2025, Daniel has previously held the position of Senior Design Assurance Engineer at Oxford Endovascular Ltd. from March 2024 to May 2025. Prior to that, Daniel worked as a QA Engineer at Abbott Diabetes Care from October 2018 to March 2024. Daniel's career began at Lombard Medical Technologies, where various roles included Senior Development Quality Engineer, Development Quality Engineer, Verification and Validation Engineer, Development Engineer, and Graduate Development Engineer from April 2010 to September 2018. Daniel holds a degree in Medical Engineering (International) from the University of Leeds, completed between 2005 and 2009, and attended Maidstone Grammar School from 1998 to 2005.
This person is not in any teams
This person is not in any offices
Lombard Medical Limited
Lombard Medical Limited is an Oxfordshire, UK-based medical device company focused on the market for minimally invasive treatment of aortic aneurysms (TAA/AAA). The Company has global regulatory approval for Aorfix™, an endovascular stent graft which has been specifically designed to treat patients with the broadest range of AAA anatomies, including aortic neck angulation up to 90 degrees. Lombard also manufactures the Altura™ stent graft, an innovative ultra-low profile device with a unique easy to use design that lends itself to day case EVAR, and which has been widely used in the repair of other failing EVAR devices. Lombard now also supplies the Minos™ ultra-low profile AAA stent graft, as well as the low profile Hercules™ TAA system. We continue to innovate and look for ways to enhance and increase the options physicians have to treat their patients.